In the complex and ever-evolving world of cancer research, one thing is certain—any treatment breakthroughs will be born out of enormous quantities of highly-quality, real-world data. Nobody understands this better than the professionals at M2GEN, who have made it their mission to help accelerate the development of more personalized cancer therapies through advanced data collection protocols and oncology-focused informatics services. Through our patented Total Cancer Care® (TCC) protocol, M2GEN has created one of the world’s largest registries of consented oncology patients. The TCC Active Clinical Registry offers our partners access to a continuously expanding base of consented patients to design custom data generation studies.
Under the Total Cancer Care protocol, patients consent to having their data collected over the course of their lifetime and agree to be re-contacted. This method allows us to build active cohorts of vital patients to facilitate a wide range of data generation to accelerate discovery, development, regulatory and safety, market access, commercial and market expansion use cases. Our clients can design:
Custom data generation services enabled by TCC Active Clinical Registry can produce clinical and molecular datasets over defined intervals. TCC Active Clinical Registry studies and projects can collect a wide range of data including:
Eliminate the need to purchase and integrate multiple disparate data sets and the guessing game of patient and data deduping. Design studies that meet your specific objectives and generate the regulatory grade data that is designed for specific use and ensures commercial success.